A carregar...
Androgen deprivation and immunotherapy for the treatment of prostate cancer
Prostate cancer is the most common newly diagnosed malignancy in men, and the second most common cause of cancer-related death in the United States. The primary treatment for recurrent prostate cancer is androgen deprivation, and this therapy is typically continued life-long for patients with metast...
Na minha lista:
| Publicado no: | Endocr Relat Cancer |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5669826/ https://ncbi.nlm.nih.gov/pubmed/28814451 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/ERC-17-0145 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|